chr9-104536713-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001961.3(OR13C3):āc.11T>Cā(p.Ile4Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,613,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001961.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR13C3 | NM_001001961.3 | c.11T>C | p.Ile4Thr | missense_variant | 1/1 | ENST00000641090.1 | |
LOC107987105 | XR_007061705.1 | n.635-6381T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR13C3 | ENST00000641090.1 | c.11T>C | p.Ile4Thr | missense_variant | 1/1 | NM_001001961.3 | P1 | ||
ENST00000668299.1 | n.899A>G | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000144 AC: 36AN: 250654Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135500
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461546Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727082
GnomAD4 genome AF: 0.000492 AC: 75AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2021 | The c.101T>C (p.I34T) alteration is located in exon 1 (coding exon 1) of the OR13C3 gene. This alteration results from a T to C substitution at nucleotide position 101, causing the isoleucine (I) at amino acid position 34 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at